← Back to Search

Device

Treatment of lower extremity lesion via transradial access. for Peripheral Arterial Disease (R2P Registry Trial)

N/A
Waitlist Available
Led By Mehdi Shishehbor, DO
Research Sponsored by Terumo Medical Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up procedure
Awards & highlights
No Placebo-Only Group

Summary

This study is designed to collect data on the complication rates and procedural success of using a transradial access approach to treat peripheral lesions in the lower extremities of a real world population.

Eligible Conditions
  • Peripheral Arterial Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and procedure for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Procedural Success
Radial access site complications

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Treatment of lower extremity lesion via transradial access.Experimental Treatment1 Intervention
Interventions performed are standard of care for treatment of a peripheral lesion.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Peripheral Artery Treatment
2020
N/A
~120

Find a Location

Who is running the clinical trial?

Terumo Medical CorporationLead Sponsor
24 Previous Clinical Trials
10,308 Total Patients Enrolled
3 Trials studying Peripheral Arterial Disease
516 Patients Enrolled for Peripheral Arterial Disease
Mehdi Shishehbor, DOPrincipal InvestigatorUniversity Hospitals, Cleveland, OH
1 Previous Clinical Trials
333 Total Patients Enrolled
1 Trials studying Peripheral Arterial Disease
333 Patients Enrolled for Peripheral Arterial Disease
~22 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top